Again, orforglipron is still being studied and in late clinical trials, but heres the expected timeline: Eli Lilly plans to submit it to the FDA in late 2025 for approval for weight loss in adults with a BMI of 30 or higher, or 27 and higher with a related health condition
[PUBMED Abstract] Bergholm U, Bergstrm R, Ekbom A: Long-term follow-up of patients with medullary carcinoma of the thyroid
Want to learn more about bariatric and metabolic health nutrition
[169] Adequate calcium and vitamin D intake may be important for bone health, particularly during long-term treatment
Overall, LVLUP Health Wolverine presents a compelling option for those seeking a supplement designed for optimal performance and recovery
A coalition of infectious disease groups issued a joint statement Friday stating that the new charter changes the fundamental focus, membership structure and governance of the committee. In this new charter, governance of the committee would be the responsibility of the CDC director instead of members with deep expertise on immunization, which would intensify politicization of the ACIP, said the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Healthcare Epidemiology of America, and Society of Infectious Diseases Pharmacists
